Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines.

about

Role of local ablative therapy for hepatocellular carcinoma Management of lymph nodes during resection of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a systematic review.Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review.

P2860

Q30417048-1D62A111-6CBD-4025-8BC4-1EE9576C2C99 Q38258604-55FDAFED-8D3C-4382-854C-2DE3CD836DFF Q55268879-18065EE7-5F37-48DD-B0C1-4B703153498B

P2860

Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines.

Item

http://www.wikidata.org/entity/Q51168197

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines.

@en

Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines.

@nl

type

Item

label

Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines.

@en

Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines.

@nl

prefLabel

Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines.

@en

Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines.

@nl

P1476

Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines.

@en

P2093

Dolores Isla

http://www.w3.org/2001/XMLSchema#string

Jaime Feliu

http://www.w3.org/2001/XMLSchema#string

Javier Sastre

http://www.w3.org/2001/XMLSchema#string

Joan Maurel

http://www.w3.org/2001/XMLSchema#string

P2860

Sorafenib in advanced hepatocellular carcinoma

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Management of hepatocellular carcinoma

Prognosis of hepatocellular carcinoma: the BCLC staging classification

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer.

Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.

Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009

Flowcharts for the management of biliary tract and ampullary carcinomas.

P2888

s12094-011-0694-x

P304

536-544

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12094-011-0694-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21821487

http://www.w3.org/2001/XMLSchema#string

Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines.

about

P2860

P2860

Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698